Effective 2/28/2016

Medicare covers percutaneous left atrial appendage closure (LAAC) for non-valvular atrial fibrillation when the device has received FDA premarket approval and the beneficiary’s condition meets certain requirements. (Posted 2/8/2016)
Decision Memo for Percutaneous Left Atrial Appendage (LAA) closure therapy (CAG-00445N)